The 3D bioprint market is expected to reach over $ 1.8 billion by 2028 – Exclusive report from Vantage Market Research

WASHINGTON, January 26, 2022 (GLOBE NEWSWIRE) – The global 3D bioprint market size is expected to reach over $ 1.8 billion in 2028 and exhibit a compound annual growth rate (CAGR) of 13.6% over the 2020-2028 forecast period. .

Market overview

The market growth is due to a certain number of organ donors and an increasing aging population with diseases related to chronic respiratory tract. Rising investment in research and development (R&D), increasing incidence of chronic diseases and technological advances are other influencing factors that are likely to boost market growth in the coming years during the forecast period, says Vantage Market Research in a report entitled 3d bioprint market by technology (ink-based, magnetic levitation, syringe-based, laser-based), by application (medical, dental, biosensors, consumer / personal product testing), by region (North America, Latin America, Europe, Asia Pacific) – Global Industry Assessment (2016 – 2021) & Forecast (2022 – 2028) “.

Click here to access the free trial report @

(The free trial of this report is readily available upon request).

Our free trial reports include:

  • In-depth industry analysis, introduction, overview and COVID-19 pandemic outbreak.

  • Impact analysis 170+ pages research report (including latest research)

  • Provide chapter-by-step guidance on query 2021 Updated regional analysis with graphical representation of trends, size and share, Includes updated list of figures and tables.

  • Updated report includes major market players with their sales volume, business strategy and revenue analysis using Vantage Market Research Methodology.

(Please note that the sample of this report has been updated to include the COVID-19 impact study before delivery.)

List of prominent players in the 3D Bioprinting market:

Market dynamics:

Driver: Rise of COVID-19 cases

Recent pandemic caused due to the collapse of coronavirus and has taken hold in the world, even developed nations see their health systems overloaded and tired. Therefore, in response to the growing cases of COVID-19, several communities associated with 3D Bioprinting are responding to the crises by providing their respective capabilities to ease the stress on governments and the supply chain worldwide.

As cases increase every day, there has been a shortage of materials for the professional in the medical industry and for the common people. One of the biggest problems is the lack of test kits available for COVID-19. Therefore, several 3D bioprint market players make 3D printers and related software on a large scale.

Driver: Development of vaccine and drug testing

The COVID-19 pandemic has also facilitated the development of vaccine and drug testing, as researchers (in patients) take advantage of new technology after preclinical trials have been completed for safety testing. With the ever-growing cases of coronavirus, the medical industry is also facing a shortage of ventilators and respirators. This 3D bioprint technology allows the manufacture of fans and respirators to overcome the shortage of these devices. Several biotherapeutic actors are using this technology to advance COVID-19 research.

Buy this Premium Report Now @

Benefits of Buying 3D Bioprinting Market Reports:

  • Customer satisfaction: Our team of experts helps you with all your research needs and optimizes your reports.

  • Analyst support: Before or after purchasing the report, ask a professional analyst to answer your questions.

  • Safe quality: Focuses on accuracy and quality of reports.

  • Incomparable skills: Analysts provide in-depth insight into reports.

Regional trends

North America is likely to experience upward growth for the 3D Bioprinting market over the expected period. The Government of Nations spends more on R&D to come up with an antidote to this condition. Due to this factor, there is an increasing demand for this 3D bioprinting as it has been reconnoitered for organ transplantation and drug testing.

Recent developments

  • September 2020: CELLINK launched its newly developed BIO X6, which is a bioprint system with six printheads that allows the combination of different materials, tools and cells. It also offers an intelligent replaceable printhead system supported by CELLINK’s patented Clean Chamber Technology. This product can help improve advanced research and clinical applications.

  • January 2020: 3D Systems and CollPlant Biotechnologies announced a joint development agreement to play a key role in promoting and accelerating innovations in the biomedical industry. This alliance may be focusing on the development of regenerative medicine using 3D bioprint.

  • December 2019: CELLINK, a Swedish manufacturer of 3D bioprinters, collaborated with the maker of micro-gravity, Made in Space, with the aim of identifying 3D bioprint development opportunities for the International Space Station (ISS).

Read the full research report @

COVID-19 impact assessment

The COVID-19 outbreak has affected various industries worldwide. Governments around the world implemented strict decommissioning measures and social distance norms to limit the rapid spread of the pandemic. Production facilities around the world were shut down in the initial stages of the pandemic. In addition, the post-pandemic economic crisis could lead to a significant delay in the commercial rollout of the 3D Bioprinting Market. Therefore, market participants faced several challenges when supply chain disruptions were observed. But things will get better in the second half of 2022 as more supplies will come online. The impact of COVID-19 on market demand is taken into account while estimating the current and expected market size and market growth trends for all regions and countries based on the following data points:

  1. Impact assessment of the COVID-19 pandemic

    1. North America

    2. Europe

    3. Asia and the Pacific

    4. Latin America

    5. Middle East and Africa

  2. Quarterly market revenue forecast of Asia Pacific 2020 and 2021

  3. Key Strategies Initiated by Companies to Tackle COVID-19

  4. Long-term dynamics

  5. Short-term dynamics

The report on 3D Bioprinting Market highlights:

  • Assessment of the market

  • Premium insight

  • Competitive landscape

  • COVID impact analysis

  • Historical data, estimates and forecast

  • Company profiles

  • Global and regional dynamics

Talk to analyst @

Key questions answered in the report:

  • Which regional market will show the highest and fastest growth?

  • What are the top five players in the 3D Bioprinting market?

  • How will the 3D Bioprinting market change in the next six years?

  • Which application and which product will take a major share of the 3D bioprint market?

  • What are 3D Bioprinting market drivers and restrictions?

  • What will be the CAGR and the size of the 3D Bioprinting market throughout the forecast period?

This market entitled “3D bioprint market “ will cover exclusive information in the form of regional analysis, forecasting and quantitative data units, key market trends and various others as mentioned below:

Report attributes


Market size in 2021

USD 1.5 billion

Expected market size in 2028

USD 1.8 billion

CAGR growth rate

CAGR of 13.6% from 2022-2028

Base year


Historical years

2016 – 2020

Forecast year

2022 – 2028

Covered segments

Technology: – Inkjet-based, Magnetic Levitation, Syringe-based, Laser-based, Other

Applications: – Medical, Dental, Biosensors, Consumer / Personal Product Testing, Bio Ink, Food and Animal Product, Other

Quantitative data units

Revenue in USD Million / Billion and CAGR from 2022 to 2028

Covered regions

North America, Europe, Asia Pacific, Latin America and the Middle East and Africa

Covered countries

USA, Canada, Mexico, UK, Germany, France, Italy, Spain, China, India, Japan, South Korea, Brazil, Argentina, GCC countries and South Africa, among others

Report coverage

Market growth drivers, constraints, opportunities, Porter’s five forces analysis, PEST analysis, value chain analysis, regulatory landscape, market attraction analysis by segments and region, analysis of the company’s market shares and COVID-19 impact analysis.

Customizing the report:

The report can be adapted to the customer’s needs or requirements. For any questions, please contact us at or +1 (202) 380-9727. Our sales managers will be happy to understand your needs and provide you with the most suitable reports.

Download free trial report now @

Browse more related report:

About Vantage Market Research:

Vantage Market Research is a reputable company committed to providing high quality data and market research services. The company delivers high-quality quantified B2B research in more than 20,000 new markets. The company offers detailed reports on several industries including chemical materials and energy, food and beverage, healthcare, technology, etc. The company includes over 125 analysts and consultants who add more than 1,100 market research reports to its huge database each year. The company’s customer base spans 70% of the Global Fortune 500 companies.

Follow us on LinkedIn:

Follow us on Twitter:

Contact us

Erik Kunz

6218 Georgia Avenue NW Ste 1 – 564

Washington DC 20011-5125

USA Tel: +1 202 380 9727



Latest press releases from Vantage Market Research @

Latest Vantage Market Research Blog @


Leave a Comment